Protamine stimulates bone sialoprotein gene expression

Gene

Volumn 516, Issue 2, 2013, Pages 228-237

  Zhou, Liming ^a,b   Matsumura, Hiroyoshi ^a   Mezawa, Masaru ^a   Takai, Hideki ^a   Nakayama, Yohei ^a   Mitarai, Makoto ^c   Ogata, Yorimasa ^a  

^a NIHON UNIVERSITY   (Japan)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c Maruha Nichiro Holdings Inc   (Japan)

Author keywords

Bone sialoprotein; Osteoblasts; Protamine; Transcription

Indexed keywords

BONE SIALOPROTEIN; FIBROBLAST GROWTH FACTOR 2; LUCIFERASE; MESSENGER RNA; PROTAMINE SULFATE; SMAD1 PROTEIN; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE METABOLISM; BONE MINERALIZATION; COMPLEX FORMATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DRUG EFFECT; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; HEMATOPOIESIS; IMMUNE RESPONSE; METABOLISM; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; RAT; TRANSIENT TRANSFECTION;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION; GENES, REPORTER; INTEGRIN-BINDING SIALOPROTEIN; LUCIFERASES; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTAMINES; RATS; TRANSFECTION;

RATTUS;

EID: 84873249814     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.056     Document Type: Article

References (58)

1. Alberts A.S., Arias J., Hagiwara M., Montminy M.R., Feeramiso J.R. Recombinant cyclic AMP response element binding protein (CREB) phosphorylated on ser-133 is transcriptionally active upon its introduction into fibroblast nuclei. J. Biol. Chem. 1994, 269:7623-7630.
2. Araki S., et al. Parathyroid hormone regulation of the human bone sialoprotein gene transcription is mediated through two cAMP response elements. J. Cell. Biochem. 2009, 106:618-625.
3. Balhorn R. The protamine family of sperm nuclear proteins. Genome Biol. 2007, 8:227.
4. Bellahcène A., Merville M.P., Castronovo V. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res. 1994, 54:2823-2826.
5. Benson M.D., Aubin J.E., Xiao G., Thomas P.E., Franceschi R.T. Cloning of a 2.5kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites. J. Bone Miner. Res. 1999, 14:396-405.
6. Benson M.D., et al. Identification of a homeodomain binding element in the bone sialoprotein gene promoter that is required for its osteoblast-selective expression. J. Biol. Chem. 2000, 275:13907-13917.
7. Bianco P., Fisher L.W., Young M.F., Termine J.D., Robey P.G. Expression of bone sialoprotein (BSP) in developing human tissues. Calcif. Tissue Int. 1991, 49:421-426.
8. Carr J.A., Silverman N. The heparin-protamine interaction. A review. J. Cardiovasc. Surg. (Torino) 1999, 40:659-666.
9. Chen J., Shapiro H.S., Wrana J.L., Reimer S., Heersche J.N.M., Sodek J. Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 1991, 11:133-143.
10. Chen J., Shapiro H.S., Sodek J. Developmental expression of bone sialoprotain mRNA in rat mineralized connective tissues. J. Bone Miner. Res. 1992, 7:987-997.
11. Chen B.P., Liang G., Whelan J., Hai T. ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J. Biol. Chem. 1994, 269:15819-15826.
12. Fukushima T., et al. Polycationic protamine for water-insoluble complex formation with DNA. Dent. Mater. J. 2010, 29:529-535.
13. Ganss B., Kim R.H., Sodek J. Bone sialoprotein. Crit. Rev. Oral Biol. Med. 1999, 10:79-98.
14. Hassan M.Q., et al. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J. Biol. Chem. 2006, 281:40515-40526.
15. Hoodless P.A., et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996, 85:489-500.
16. Horrow J.C. Protamine: a review of its toxicity. Anesth. Analg. 1985, 64:348-361.
17. Hu J., Qu C., Yu Y., Ping M., Wei D., Dandan D. Protamine sulfate downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF and its receptor binding in vitro. Adv. Exp. Med. Biol. 2010, 664:341-347.
18. Huang Y.Q., Li J.J., Nicolaides A., Zhang W.G., Friedman-Kien A.E. Increased expression of fibroblast growth factors (FGFs) and their receptor by protamine and suramin on Kaposi's sarcoma-derived cells. Anticancer Res. 1993, 13:887-890.
19. Hunter G.K., Goldberg H.A. Nucleation of hydroxyapatite by bone sialoprotein. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8562-8565.
20. Ibrahim T., et al. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin. Exp. Metastasis 2000, 18:253-260.
21. Jheon A., Bansal A.K., Zhu B., Ganss B., Cheifetz S., Sodek J. Characterisation of the constitutive over-expression of AJ18 in a novel rat stromal bone marrow cell line (D8-SBMC). Arch. Oral Biol. 2009, 54:705-716.
22. Johansen C., Gill T., Gram L. Antibacterial effect of protamine assayed by impedimetry. J. Appl. Bacteriol. 1995, 78:297-303.
23. Kerr J.M., Fisher L.W., Termine J.D., Wang M.G., Mcbride O.W., Young M.F. The human bone sialoprotein gene (IBSP): genomic localization and characterization. Genomics 1993, 17:408-415.
24. Kim R.H., Sodek J. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box. Cancer Res. 1999, 59:565-571.
25. Kim R.H., Shapiro H.S., Li J.J., Wrana J.L., Sodek J. Characterization of the human bone sialoprotein (BSP) gene and its promoter sequence. Matrix Biol. 1994, 14:31-40.
26. Kiyoshima T., Yamauchi M., Wong C., Jheon A., Ganss B., Sodek J. An L1 element disrupts human bone sialoprotein promoter: lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein 2 (Runx2)/core binding factor a1 (Cbfa1) elements. Gene 2002, 299:205-217.
27. Komori T., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
28. Laoide B.M., Foulkes N.S., Schlotter F., Sassone-Corsi P. The functional versatility of CREM is determined by its modular structure. EMBO J. 1993, 12:1179-1191.
29. Li J.J., Sodek J. Cloning and characterization of the rat bone sialoprotein gene promoter. Biochem. J. 1993, 289:625-629.
30. Li J.J., Kim R.H., Sodek J. An inverted TATA box directs downstream transcription of the bone sialoprotein gene. Biochem. J. 1995, 310:33-40.
31. Li X., et al. Transcriptional regulation of bone sialoprotein gene by Porphyromonas gingivalis lipopolysaccharide. J. Cell. Biochem. 2010, 110:823-833.
32. Li Z., et al. cAMP and fibroblast growth factor 2 regulate bone sialoprotein gene expression in human prostate cancer cells. Gene 2011, 471:1-12.
33. Liu K.X., Kato Y., Kaku T.I., Matsumoto K., Nakamura T., Sugiyama Y. Protamine enhances the proliferative activity of hepatocyte growth factor in rats. Am. J. Physiol. 1998, 274(1 Pt. 1):G21-G28.
34. Liu K.X., Kato Y., Matsumoto K., Nakamura T., Kaku T., Sugiyama Y. Characterization of the enhancing effect of protamine on the proliferative activity of hepatocyte growth factor in rat hepatocytes. Pharm. Res. 2009, 26:1012-1021.
35. Lokeshwar V.B., Huang S.S., Huang J.S. Protamine enhances epidermal growth factor (EGF)-stimulated mitogenesis by increasing cell surface EGF receptor number. Implications for existence of cryptic EGF receptors. J. Biol. Chem. 1989, 264:19318-19326.
36. Mezawa M., et al. Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB. Gene 2009, 435:80-87.
37. Nakayama Y., et al. Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP gene. J. Cell. Physiol. 2006, 208:326-335.
38. Nakayama Y., Yang L., Takai H., Kaneko H., Abiko Y., Ogata Y. Fibroblast growth factor 2 and forskolin induce mineralization-associated genes in two kinds of osteoblast-like cells. J. Oral Sci. 2012, 54:251-259.
39. Newberry E.P., Latifi T., Towler D.A. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins. Biochemistry 1998, 37:16360-16368.
40. Ogata Y. Bone sialoprotein and its transcriptional regulatory mechanism. J. Periodontal Res. 2008, 43:127-135.
41. Ogata Y., Yamauchi M., Kim R.H., Li J.J., Freedman L.P., Sodek J. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression: identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur. J. Biochem. 1995, 230:183-192.
42. Ogata Y., et al. Transforming growth factor-β1 regulation of bone sialoprotein gene transcription: identification of a TGF-β activation element in the rat BSP gene promoter. J. Cell. Biochem. 1997, 65:501-512.
43. Ogata Y., et al. Parathyroid hormone regulation of bone sialoprotein (BSP) gene transcription is mediated through a pituitary specific transcription factor-1 (Pit-1) motif in the rat BSP gene promoter. Matrix Biol. 2000, 19:395-407.
44. Oldberg Å., Franzen A., Heinegård D. The primary structure of a cell-binding bone sialoprotein. J. Biol. Chem. 1988, 263:19430-19432.
45. Poli V., Mancini F.P., Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 1990, 63:643-653.
46. Samee N., de Vernejoul M.C., Levi G. Role of DLX regulatory proteins in osteogenesis and chondrogenesis. Crit. Rev. Eukaryot. Gene Expr. 2007, 17:173-186.
47. Samoto H., et al. Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and FGF2 response elements in the proximal promoter of the rat BSP gene. J. Biol. Chem. 2003, 278:28659-28667.
48. Samuel R.E., et al. Osteoconductive protamine-based polyelectrolyte multilayer functionalized surfaces. Biomaterials 2011, 32:7491-7502.
49. Sassone-Corsi P. Transcription factors responsive to cAMP. Annu. Rev. Cell Dev. Biol. 1995, 11:355-377.
50. Shimizu E., et al. Fibroblast growth factor 2 and cyclic AMP synergistically regulate bone sialoprotein gene expression. Bone 2006, 39:42-52.
51. Shimizu-Sasaki E., Yamazaki M., Furuyama S., Sugiya H., Sodek J., Ogata Y. Identification of a novel response element in the rat bone sialoprotein (BSP) gene promoter that mediates constitutive and fibroblast growth factor 2-induced expression of BSP. J. Biol. Chem. 2001, 276:5459-5466.
52. Shirakabe K., Terasawa K., Miyama K., Shibuya H., Nishida E. Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 2001, 6:851-856.
53. Waltregny D., Bellahcène A., Leval X.D., Florkin B., Weidle U., Castronovo V. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers. J. Bone Miner. Res. 2000, 15:834-843.
54. Wang Z., et al. Effects of inorganic polyphosphate on bone sialoprotein gene expression. Gene 2010, 452:79-86.
55. Wang M., Jin H., Tang D., Huang S., Zuscik M.J., Chen D. Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis Cartilage 2011, 19:751-762.
56. Wang S., et al. Transcriptional regulation of bone sialoprotein gene by interleukin-11. Gene 2011, 476:46-55.
57. Yamauchi M., Ogata Y., Kim R.H., Li J.J., Freedman L.P., Sodek J. AP-1 regulation of the rat bone sialoprotein gene transcription is mediated through a TPA response element within a glucocorticoid response unit in the gene promoter. Matrix Biol. 1996, 15:119-130.
58. Yang L., et al. Kaempferol stimulates bone sialoprotein gene transcription and new bone formation. J. Cell. Biochem. 2010, 110:1342-1355.